Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis-Reference-Cited by-同舟云学术

Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis

Published:2014-01 Issue:1 Volume:19 Page:37-48
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Schoors Sandra,De Bock Katrien,Cantelmo Anna Rita,Georgiadou Maria,Ghesquière Bart,Cauwenberghs Sandra,Kuchnio Anna,Wong Brian W.,Quaegebeur Annelies,Goveia Jermaine,Bifari Francesco,Wang Xingwu,Blanco Raquel,Tembuyser Bieke,Cornelissen Ivo,Bouché Ann,Vinckier Stefan,Diaz-Moralli Santiago,Gerhardt Holger,Telang Sucheta,Cascante Marta,Chesney Jason,Dewerchin Mieke,Carmeliet Peter

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference37 articles.

1. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge;Cavallaro;Acta Ophthalmol. (Copenh.),2013

2. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect;Chesney;Proc. Natl. Acad. Sci. USA,1999

3. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth;Clem;Mol. Cancer Ther.,2008

4. Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer;Clem;Mol. Cancer Ther.,2013

5. Red cell glycolytic enzyme disorders caused by mutations: an update;Climent;Cardiovasc. Hematol. Disord. Drug Targets,2009

Cited by 443 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcription Factor MAZ Potentiates the Upregulated NEIL3-mediated Aerobic Glycolysis, thereby Promoting Angiogenesis in Hepatocellular Carcinoma;Current Cancer Drug Targets;2024-12

2. Pathogenic role of PFKFB3 in endothelial inflammatory diseases;Frontiers in Molecular Biosciences;2024-09-10

3. Glycolysis, the sweet appetite of the tumor microenvironment;Cancer Letters;2024-09

4. Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

5. Therapeutic efficacy of ECs Foxp1 targeting Hif1α-Hk2 glycolysis signal to restrict angiogenesis;Redox Biology;2024-09